WASHINGTON, Jan. 11, 2016 /PRNewswire/ -- Danaher
Corporation (NYSE: DHR) (the "Company") announced that its
President and Chief Executive Officer, Thomas P. Joyce, Jr., will comment tomorrow on
the Company's fourth quarter 2015 performance in a presentation at
the J.P. Morgan Healthcare Conference in San Francisco, CA at 11:30 a.m. PST. Mr. Joyce will communicate that
Danaher's fourth quarter 2015 adjusted diluted net earnings per
share is expected to be approximately at the mid-point of the
Company's previously announced guidance.
As previously announced, Danaher will hold its quarterly
earnings conference call for the fourth quarter and year-end 2015
on Tuesday, January 26, 2016 at
8:00 a.m. EST.
ABOUT DANAHER
Danaher is a global science and
technology innovator committed to helping its customers solve
complex challenges and improving quality of life around the world.
Its family of world class brands have unparalleled leadership
positions in some of the most demanding and attractive industries,
including health care, environmental and industrial. The company's
globally diverse team of 80,000 associates is united by a common
culture and operating system, the Danaher Business System. In 2014,
Danaher generated $19.9 billion in
revenue and its market capitalization exceeded $60 billion. For more information please visit
www.danaher.com.
FORWARD LOOKING STATEMENTS
Statements in this release
that are not strictly historical, including the statements
regarding the Company's anticipated adjusted diluted net earnings
per share for the fourth quarter of 2015 and any other statements
regarding events or developments that we believe or anticipate will
or may occur in the future, are "forward-looking" statements within
the meaning of the federal securities laws. There are a number of
important factors that could cause actual results, developments and
business decisions to differ materially from those suggested or
indicated by such forward-looking statements and you should not
place undue reliance on any such forward-looking statements. These
factors include, among other things, deterioration of or
instability in the economy, the markets we serve and the financial
markets, the impact of our restructuring activities on our ability
to grow, contractions or growth rates and cyclicality of markets we
serve, competition, our ability to develop and successfully market
new products and technologies and expand into new markets, the
potential for improper conduct by our employees, agents or business
partners, our ability to successfully identify, consummate and
integrate appropriate acquisitions and successfully complete
divestitures and other dispositions, contingent liabilities
relating to acquisitions and divestitures, our ability to
successfully consummate the separation of Danaher into two public
companies and realize the anticipated benefits of that transaction,
our compliance with applicable laws and regulations (including
regulations relating to medical devices and the healthcare
industry) and changes in applicable laws and regulations, our
ability to effectively address cost reductions and other changes in
the healthcare industry, risks relating to potential impairment of
goodwill and other intangible assets, currency exchange rates, tax
audits and changes in our tax rate and income tax liabilities,
litigation and other contingent liabilities including intellectual
property and environmental, health and safety matters, risks
relating to product, service or software defects, product liability
and recalls, risks relating to product manufacturing, the impact of
our debt obligations on our operations and liquidity, our
relationships with and the performance of our channel partners,
commodity costs and surcharges, our ability to adjust purchases and
manufacturing capacity to reflect market conditions, reliance on
sole sources of supply, labor matters, international economic,
political, legal, compliance and business factors, disruptions
relating to man-made and natural disasters, security breaches or
other disruptions of our information technology systems and pension
plan costs. Additional information regarding the factors that may
cause actual results to differ materially from these
forward-looking statements is available in our SEC filings,
including our 2014 Annual Report on Form 10-K and Quarterly Report
on Form 10-Q for the third quarter of 2015. These forward-looking
statements speak only as of the date of this release and the
Company does not assume any obligation to update or revise any
forward-looking statement, whether as a result of new information,
future events and developments or otherwise.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/danaher-ceo-to-comment-on-financial-performance-300202665.html
SOURCE Danaher Corporation